Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis is a chronic inflammatory disorder associated with joint inflammation, progressive tissue damage, and oxidative stress. Vanillic acid, a phenolic compound with reported anti-inflammatory and antioxidant properties, may have potential in mitigating these pathological changes. This study aimed to evaluate the anti-arthritic and anti-inflammatory potential of vanillic acid in a Freund’s complete adjuvant (FCA)-induced arthritic Sprague Dawley albino rat model. Arthritis was induced on day 0 in all rats except the normal control group, and treatment was initiated on the same day following FCA administration. All treatments were administered for 21 consecutive days. Arthritic progression, paw volume, and paw thickness were assessed on Days 5, 9, 13, 17, and 21 using arthritic scoring, a water-displacement plethysmometer, and a digital Vernier caliper, respectively. Histopathological examination of ankle joints was performed using the hematoxylin and eosin (H&E) staining method. Serum superoxide dismutase (SOD) activity, malondialdehyde (MDA), and reduced glutathione (GSH) levels were assessed using spectrophotometric methods to evaluate oxidative stress and antioxidant status. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to evaluate the expression of interleukin-6 (IL-6), interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and hypoxia-inducible factor-1 alpha (HIF-1α), while hematological parameters were also assessed. Vanillic acid significantly reduced arthritic scores, paw thickness, and paw volume, particularly during the later stages of treatment (all treatment groups, p < 0.001 on Day 21 compared with the arthritic control group). Histopathological examination showed marked inflammatory changes in the arthritic control group, whereas relatively preserved joint architecture was observed in the HDVA group, with comparatively fewer apparent pathological changes in the vanillic acid-treated groups. The arthritic control group showed increased expression of TNF-α, IL-1β, IL-6, and HIF-1α, whereas vanillic acid treatment significantly attenuated their expression (TNF-α: p < 0.001 at all doses; IL-1β: p < 0.01 at 200 and 400 mg/kg; IL-6: p < 0.05 at 100 mg/kg and p < 0.001 at 200 and 400 mg/kg; HIF-1α: p < 0.05 at 100 mg/kg and p < 0.01 at 200 and 400 mg/kg). Vanillic acid also increased SOD activity and GSH levels while reducing MDA concentrations compared with the arthritic control group (SOD, GSH, and MDA: p < 0.01 at 100 mg/kg and p < 0.001 at 200 and 400 mg/kg). In the present study, vanillic acid demonstrated anti-arthritic and immunomodulatory potential in the FCA-induced rat model of arthritis, associated with attenuation of inflammatory mediators and improvement in measured antioxidant parameters. These findings are limited to this experimental animal model and should not be interpreted as evidence of clinical efficacy in human rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: